Obstetric patients present a unique challenge in medicine as these patients cannot be treated as a “normal” adult due to changes in pharmacokinetic and pharmacodynamic properties. Additionally, there are specific disease states that only impact the obstetric population. The goal of this webinar is to explore the role that pharmacists can have in caring for obstetric patients. In addition to describing published literature, the speakers will share information about their own personal experiences working alongside the multidisciplinary team caring for this niche population.

Explain clinical pharmacy services in obstetrics

Summarize literature supporting clinical pharmacy services in obstetrics

Relate personal experiences with pharmacists in the obstetrics setting

FIP Boards, Sections, SIGs, group and/or external partners involved in the planning and delivery. These groups and their logos will be used for marketing purposes.

Moderator:
Noelle Leung, Maternal Fetal Medicine and Obstetrics Clinical Pharmacist, University of Kentucky Health Care - USA

Speakers:
Lauren Leader, Clinical Pharmacist Specialist - Obstetrics and Gynecology Michigan Medicine | University of Michigan College of Pharmacy - USA
Camila Rios, Pharmaceutical Coordinator Hospital de Alta Complejidad - Argentina
Molly Stout, Division Chief, Maternal Fetal Medicine, Michigan Medicine - USA

The COVID-19 pandemic has created an urgent need for diagnostic testing of patients and populations. In response, a multitude of COVID-19 tests are available to use from many different manufacturers and organisations. FIP has created a counselling information guide to assist practising pharmacists around the world in talking to patients who have questions concerning COVID-19 tests. This joint FIP-ASHP online event will present the newly developed guidance on Evaluation of Diagnostic Testing & Methods, as well as tools for pharmacists developed by the American Society of Health-System Pharmacists (ASHP). Panellists will discuss issues about care and how to manage the risks with evidence is the focus.

Moderator:
Zuzana Kusynova, Lead for Policy, Practice and Compliance, FIP, Netherlands

Panellist:
Mary Ann Kliethermes, Director, Medication Safety and Quality, American Society of Health-System Pharmacists (ASHP), USA

Catherine Duggan, CEO, FIP, Netherlands

Julien Fonsart, Senior specialist in laboratory medicine pharmacist, Hôpital Lariboisière, Université de Paris, France

Ally Dering-Anderson, Clinical Associate Professor in the Department of Pharmacy Practice & Science, University of Nebraska College of Pharmacy, USA

Margaret Underwood, Pharmacy student & FIP Intern, FIP, USA

Jasminka N Sarunac, Lead Pharmacist Investigational drugs/Clinical trial, Pharmacoepidemiologist, John Hunter Hospital, Australia

In this episode – “Pharmacist Vaccinators and Patient Safety” – is an interview format that focuses on the FIP Development Goal 19: Patient Safety from the perspective of vaccination by a pharmacist. The role of pharmacists in delivering safe vaccinations; participation in vaccination monitoring and adverse event reporting, and the role of improving vaccination rates as a method of reducing overall harm caused by preventable disease.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 19: Patient Safety in the Transformation of Vaccination Globally and Regionally

Moderator:
Lars-Åke Söderlund, Executive Advisor, Apoteket AB - Sweden

Speakers:
Ramesh Walpola, Lecturer, School of Population Health, UNSW Sydney - Australia
John Hertig, Associate Professor, Butler University - USA
Ema Paulino, Professional Secretary, International Pharmaceutical Federation (FIP) - Portugal
Alpana Mair, Head of Prescribing and Therapeutics for Scottish Government, coordinating delivery of Governments work programme and advising Ministers on Quality, safety and effectiveness of Prescribing, Scottish Government - UK

In this episode – “Pharmacist Vaccinators as a way to improve access to medicines” – is an interview format that focuses on the FIP Development Goal 18: Access to Medicines and Services from the perspective of vaccination by a pharmacist. The role of pharmacists in ensuring that vaccinations are widely and easily accessible by all people in all areas of the world, and the expertise of pharmacists in delivering the logistics and services needed to increase vaccination rates.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 18: Access to Medicines and Services in the Transformation of Vaccination Globally and Regionally

Moderator:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Panellists:
Jane Barratt, Secretary General, International Federation on Ageing - Canada
Alexandra Ruth, Doctoral Student, Johns Hopkins Bloomberg School of Public Health - USA

The purpose of this webinar is to raise awareness and introduce the topics and format of the survey, its purpose and its alignment with the FIP Development Goals. This webinar will give you the opportunity to raise any questions about the survey and how the data it will produce may be of value to your organisation.

Programme

- Catherine Duggan - Introduction
- Chris John - GPO and alignment of this survey with FIP DGs
- Gonçalo Sousa Pinto - Community pharmacy regulation and access to professional services in the community, remuneration models
- Jaime Acosta - Online pharmacy operations, patient safety and quality use of medicines
- Q&A

Se generó, durante esta pandemia, diversos tipos de evidencia respecto a los tratamientos para la Covid-19 pero aún así, el farmacéutico se enfrenta a la necesidad de tomar decisiones en ausencia de evidencia científica. Para apoyar la toma de decisiones, se compartirán los caminos emprendidos en el Hospital G. Marañón para la selección y protocolización del tratamiento para Covid-19 mostrando las herramientas utilizadas. La segunda parte será dedicada a los sistemas de farmacovigilancia (FV) sostenibles. La FV no es una actividad de lujo sino que es la base del uso seguro de medicamentos. Involucrar al paciente. Uso off-label de medicamentos.

1. Identificar los principales retos en la selección y protocolización de los tratamientos para Covid-19 en un contexto de falta de evidencia científica.
2. Analizar rol de las agencias reguladoras, la Comisión de Farmacia y Terapéutica del hospital, el grupo de expertos Covid-19 y grupo PROA del hospital y el farmacéutico en enfermedades infecciosas.
3. Compartir la experiencia en el abordaje de la selección y protocolización del tratamiento para Covid-19.
4. Discutir estrategias para organizar sistemas sostenibles para la gestión de riesgos de productos farmacéuticos y dispositivos médicos en la farmacia hospitalaria post-Covid.

Moderadora:
Nora Gerpe, Química Farmacéutica Asociación de Química y Farmacia del Uruguay-Uruguay

Panelistas:
Carmen Rodriguez, Farmacéutica Hospitalaria Hospital General Universitario Gregorio Marañón - España
Lucila Castro Pastrana, Full Professor Universidad de las Américas, Puebla - México

In this episode – “Pharmacist Vaccinators and Antimicrobial Stewardship” – is an interview format that focuses on the FIP Development Goal 17: Antimicrobial Stewardship from the perspective of vaccination by a pharmacist. The role of vaccination in antimicrobial stewardship, preserving antimicrobial effectiveness, preventing antimicrobial resistance, and the promise of addressing these issues that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 17: Antimicrobial Stewardship in the Transformation of Vaccination Globally and Regionally

Moderator:
Sabiha Essack, South African Research Chair in Antibiotic Resistance & One Health Chair: Global Respiratory Infection Partnership, University of KwaZulu-Natal - South Africa

Speakers:
Alfonso Pereira Céspedes, Pharmacist, University of Costa Rica - Costa Rica
Manjiri Gharat, Vice President, Indian Pharmaceutical Association - India
Philip Howard, Consultant Pharmacist, Leeds Teaching Hospitals NHS Trust - UK
Debra Goff, The Ohio State University Medical Center - USA

In this episode – “Pharmacist Vaccinators and Communicable Disease Management” – is an interview format that focuses on the FIP Development Goal 16: communicable and Vector Diseases from the perspective of vaccination by a pharmacist. The role of vaccination in the prevention and suppression of communicable and vector-borne disease, and the promise of addressing these diseases that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 16: Communicable and Vector Diseases in the Transformation of Vaccination Globally and Regionally

Interviewer:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Interviewee:
Michael Klepser, Past President - Society of Infectious Diseases Pharmacists; Professor of Pharmacy Practice, Ferris State University - USA

The Global COVID impact on, consumer behavior/patient expectations, healthcare, and Pharmacy workforce was noticeable.
The Importance of pharmacy technicians in healthcare delivery pre-covid, during crisis, and post-covid is crucial for the healthcare and patient services.

Learning objectives:
Understand the global/healthcare/pharmacy landscape in a time of crisis;
Learn about the impact of the evolving role of Pharmacy Technicians on patients during COVID and beyond;
Illustrate exemplars of pharmacy technicians as change agents in 3 global regions and practice environments;
Translate global best practices to overcome barriers to change and identify how to evolve the pharmacy technician role to best serve patient outcomes in your practice setting.

Moderator:
Vijay Sarma, VP Pharmacy Marketing McCann Health - Canada

Panellists:
1. Cathy Schuster, Coordinator of Pharmacy Technicians programs Canadian Council for Accreditation of Pharmacy Programs - Canada
2. Kate Thorndike, Specialist Transplant Pharmacy Technician Addenbrookes Hospital - UK
3. Nyanje Samuel, Academic Pharmacy Technician Moi Teaching and Referral Hospital Kenya Medical Training College - Kenya
4. Clara Wong, Registered Pharmacy Technician Centennial College - Pharmacy Technician Program University of Toronto – Faculty of Pharmacy - Canada

In this episode, “Removing Policy Barriers to Pharmacist Vaccination” – is an interview format that focuses on the FIP Development Goal 13: Policy Development from the perspective of vaccination by a pharmacist. We discuss the process of policy development, identification of barriers, and engagement with stakeholders to ensure that pharmacist vaccination is accessible to all people in all settings where pharmacists work.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Outcomes
To understand the impact of FIP Development Goal 13: Policy Development in the Transformation of Vaccination Globally and Regionally

Moderators:
Ellen Schafheutle, Professor of Pharmacy Policy and Practice Centre for Pharmacy Workforce Studies, The University of Manchester - United Kingdom
Chima Amadi, Education and Training Personnel Pharmacists’ Council Nigeria - Nigeria

Panellists:
1. Walter da Silva João, President Brazilian Federal Council of Pharmacy - Brazil
2. Howard Rice, Hon. President & International Liaison Officer Pharmaceutical Association of Israel - Israel
3. Shane Jackson, Community and Consultant Pharmacist - Pharmaceutical Society of Australia - Australia

The objective of this webinar is to present a summary of the most innovative research in pharmacy practice and to discuss its contribution to the pharmacy profession.

Four key speakers from Research in Social and Administrative Pharmacy will present their research in the webinar. The topics covered will involve pharmacists prescribing, implementation of professional pharmacy services, roles of pharmacists during the COVID-19 pandemic and innovative models for pharmacists providing medication reviews.

The potential audience for this webinar will be practitioners with an interest in pharmacy practice research, novel and experienced researchers.

Learning objectives:
To identify how pharmacy practice research can contribute to the practice of pharmacy
To discuss how research can inform innovate pharmacy models of care
To discuss pharmacy practice research priority areas
FIP Organizers and/or external partners

Moderator:
Victoria Garcia Cardenas, Senior Lecturer University of Technology Sydney Research in Social and Administrative Pharmacy - Australia

Panellists:
1. Shane Desselle, Professor, Editor in Chief Touro University Research in Social and Administrative Pharmacy - USA
2. Karen Luetsch, Lecturer the University of Queensland - Australia
3. Carolina Ung, Professor University of Macau - China
4. Derek Stewart, Professor of Clinical Pharmacy and Practice - Qatar University - Qatar
5. Sherilyn Houle, Professor University of Waterloo - Canada

In this episode, “Empowering Pharmacists to Deliver Vaccination in all Settings” – is an interview format that focuses on the FIP Development Goal 7: Advanced Integrated Services from the perspective of vaccination by pharmacist. We discuss change management principles in the context of integrating advanced practice services into every day practice, ensuring that vaccination by pharmacists in all settings and jurisdictions is consistent with best evidence and practice guidelines. Where a pharmacist is present in all settings, vaccinations can be provided. Ensuring collaborative work and shared documentation with all healthcare professionals to ensure it is an integrated service.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Objective
Identifying mechanisms for transforming vaccination using FIP DG7: Advancing integrated services

Moderator:
Marwan Akel, Chairperson Pharmacy Practice Department Lebanese International University - Lebanon

Panellists:
1.Barbel Holbein, Lecturer and Researcher University of Bremen; University of applied sciences-Baden Württemberg - Germany
2.Sofía Segura, Professor University of Costa Rica and College of Pharmacists of Costa Rica - Costa Rica
3. Pamela Logan, Director of Pharmacy Services Irish Pharmacy Union - Ireland
4. Scarlett Pong, President of The Pharmaceutical Society of Hong Kong - Hong Kong

In this episode – “Vaccination: From Specialist Practice to Everyday Practice” – is an interview format that focuses on the FIP Development Goal 4: Advanced & Specialist Development from the perspective of vaccination by a pharmacist. We discuss the process required to take vaccination by pharmacists from a specialized field that few pharmacists deliver in some jurisdictions, to a standard part of pharmacists’ care in all settings and locations.

Power Point slides

Moderators:
Arit Udoh, Clinical Project Manager University of Birmingham-United Kingdom
Desak Ketut Ernawati, Academic and Researcher Faculty of Medicine Universitas Udayana-Indonesia

Speakers:
1. Hanne Merete Andresen, Director Pharmaceutical Affairs Norwegian Pharmacy Association - Norway
2. Andi Shirtcliffe, Clinical Chief Advisor – Pharmacy, Quality Use of Medicines, Allied Health Ministry of Health - New Zealand
3. Greg Eberhart, Registrar Alberta College of Pharmacy-Canada
4. Jorge Batista, International Affairs Lead Portuguese Pharmaceutical Society - Portugal

La grippe saisonnière représente une charge de morbidité importante pour le système de santé et un risque pour plusieurs groupes de population, notamment les personnes âgées, les personnes souffrant d'affections sous-jacentes, les femmes enceintes et d'autres.
La menace d'une deuxième épidémie de COVID-19 est très réelle, et le risque que les deux virus entraînent une morbidité et une mortalité combinées ne peut être négligé.

Ce panel discutera comment plusieurs pays francophones relèvent ce défi grâce à la vaccination en pharmacie, et comment les pharmaciens peuvent contribuer à améliorer la couverture vaccinale contre la grippe et contre d’autres maladies évitables par la vaccination tout au long de la vie. Le panel discutera également du rôle du pharmacien d’officine dans la réponse aux doutes et aux mythes sur les vaccins. Il abordera également la question de la nécessaire collaboration interprofessionnelle et de sa valeur ajoutée pour les patients et pour la société, la vaccination en pharmacie représentant une extension et non un déplacement de l’accès à la vaccination.

Après ce webinaire, les participants devraient comprendre :
1. L'impact de la vaccination en pharmacie sur les taux de couverture vaccinale ;
2. Pourquoi les populations vulnérables (personnes âgées, patients chroniques et professionnels de la santé) devraient être vaccinées contre la grippe, en particulier dans le contexte de la pandémie;
3. Le rôle des pharmaciens dans l’amélioration de la couverture vaccinale tout au long de la vie contre différentes maladies;
4. Les stratégies adoptées par certains pays francophones pour augmenter la couverture vaccinale contre la grippe via les pharmacies et comment ils ont surmonté l'opposition liée aux corporations par des preuves et des approches collaboratives.

Scope: Transforming Vaccination with the FIP Development Goals: Brining practice, science and workforce together

What were the key insights and summaries from each of the events so far?

What was the one key message you gathered from that presentation, what was the main need identified from the presentation?

What is one key change you think that could be implemented to address this change?

Moderators:
Dominique Jordan, FIP President - Switzerland
Catherine Duggan, FIP CEO - the Netherlands

Panellists:
1. Ema Paulino, FIP Professional Secretary - Portugal
2. Paul Sinclair, Community Pharmacist Chair Board of Pharmaceutical Practice - Australia
3. Giovanni Pauletti, FIP Scientific Secretary - USA
4. Ross MacKinnon, Chair of FIP Board of Pharmaceutical Science, FIP - Australia
5. Ralph Altiere, Chair of FIP Education FIP - USA
6. Ian Bates, Chair of pharmacy education, UCL - UK
7. Allie Jo, Director, State Policy National Alliance of State Pharmacy Associations -
USA

Moderators:
Ralph Altiere, Dean University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, FIP Education Chair - USA

Facilitator:
Nilhan Uzman, FIP UNITWIN Programme Lead- The Netherlands

Panellists:
Catherine Duggan, FIP CEO - The Netherlands
Prosper Hiag, President African Pharmaceutical Forum - Cameroon
Mahama Duwiejua, Co- Founder, FIP-UNESCO UNITWIN Centre for Excellence in Africa - Ghana
George Ladaah Openjuru, UNESCO Chair, UNESCO - Uganda
Jennifer Nyoni, Acting Team leader Health Workforce Unit WHO Regional Office for Africa - Congo

Speakers:
Dominique Jordan, FIP President - Switzerland
Derick Munkombwe, FIP UNESCO-UNITWIN Center for Excellence in Africa Lead - Zambia
Mariam Boakye Gyasi, FIP UNESCO-UNITWIN Center for Excellence in Africa (CfEA) Lead - Ghana
Alison Williams, FIP-UNESCO UNITWIN Center for Excellence in Africa Project Coordinator - Nigeria
Aniekan Ekpenyong, Director for Africa, Global Health Focus - Nigeria
Khalid Mohammed Garba, FIP YPG Liaison Person for FIP-UNESCO UNITWIN CfEA-Nigeria
Stanley Ndigwah, FIP UNESCO-UNITWIN Center for Excellence in Africa Lead - Kenya

The presentation is available here.

Presentation slides are available here.

The presentation is available here.

The presentation is available here.

Speakers:
Marianne Ivey, Professor Emerita, Pharmacy Practice and Administrative Sciences FIP - USA
Jonathan Penm, Lecturer University of Sydney - Australia

Moderator:
Lars-Åke Söderlund, President, Community Pharmacy Section FIP President, Community Pharmacy Section
Sweden

Panellists:
1. Jelmer Faber, Community pharmacist and Co-founder of PharmaSwap.com, Royal Dutch Pharmacists’ Association - the Netherlands
2. Rikke Løvig Simonsen, Chair PharmaDanmark - Denmark
3. Frédéric Bassi, President of the Industrial Pharmacists Section French Chamber of Pharmacists - France

Moderator

• Catherine Duggan– (FIP, The Netherlands)

Speakers

• Ronald T. Piervincenzi, CEO, United States Pharmacopeia
• Ross Mckinnon – FIP Chair of Board of Pharmaceutical Sciences (College of Medicine and Public Health, Australia)
• Giovanni Pauletti – FIP Scientific Secretary (St. Louis College of Pharmacy, USA)

Moderator: Ross McKinnon (College of Medicine and Public Health, Australia)

Speakers: Colin Pouton (Monash Institute of Pharmaceutical Sciences, Australia), Nikolai Petrovsky, Founder and CEO, Vaxine (Australia)

Moderator: Ema Paulino

Panelists: Paul Sinclair, Yong Pei Chean, Faraz Ashraf, Manjiri Gharat, Indre Treciokiene, Samira Shammas

Slides

Moderators: Boone James L Winkle, Jarrod McMaugh
Panellists: Ian Bates, Lina Bader, Abeer Al-Ghananeem, Andreia Bruno-Tome, Barbel Holbein, Astrid Czock, Nadia Bukhari

Moderator: Eeva Teräsalmi

Panellists: Lucinda L. Maine, Mariet J Eksteen, Yinka Oguns

Moderator: Nai-Hwa Mei
Panellists: Anasemon Aioub, Edurne Fdez. de Gamarra Martínez

Chair: Zuzana Kusynová

Panellists: Dr Catherine Duggan, Sabiha Essack, Philip Howard, Debbie Goff, Eduardo Savio 

Moderators: Catherine Duggan, Lina Bader 

Speakers and Panelists: Roopa Dhatt, Adi Nuseirat, Carmen Peña, Claire Thompson, Nilhan Uzman, Nadia Bukhari, Vibhuti Arya, and Shane Desselle, Angie Lim Hui Li, Isaac Nii Ofoli Anang, Sherly Meilianti

Facilitators: Nilhan Uzman, Esther Anyango

Speakers: Meltem Agduk, Nadia Abdelhadi, Christina Chai, Leonora O’Brien, Vibhuti Arya Amirfar, Aya Jamal

Moderator: Rula Darwish

Speakers:Zeid Kilani, Falah Eddy, Ian Bates, Lina Bader, Dalia Bajis, Kirstie Galbraith

Panelists: Shepard Mhalaba, Asmaa Al Hagan, Desak Ernawati, Arit Udoh

Moderator: Catherine Duggan

Panellists: Ema Paulino, Ian Bates, Giovanni Pauletti

Mike Scott and Nicola Goodfellow interview

Moderator: Prof Ashok Soni

Panellists: Dr Michael Moore, Prof. Justin Ortiz

Moderator: Ema Paulino

Panellists: Bram Palache, Matthew Downham, Hanne Andresen, 

Moderator: Catherine Duggan

Panellists: Dominique Jordan, Sónia Queirós, Ann Lindstrand, Duarte Santos, Jane Barratt, Radu Costin Ganescu

Moderator: Lars-Åke Söderlund

Panellists: Glenis Kathleen Scadding, Gonçalo Sousa Pinto, Sundeep Santosh Salvi.

Speakres: Sabiha Essack and FIP Lead, Philip Howard, Catherine Duggan

The presentation is available here. Read the Covid-19 Special Collection by Pharmacy Education here. More on Pharmacy Education. 

The presentation is available here.

The presentation is available here.

The Quantitative Sciences group is focused on quantitative data analysis to support program strategies for therapeutic projects that the foundation funds. This effort extends across all therapeutic areas in which the foundation is involved including maternal & child health, family planning, malaria, tuberculosis, neglected tropical diseases, HIV, and pandemic preparedness. He and his team are strong advocates of making research data “always FAIR and sometimes OPEN” to improve the impact data can have towards the problem it was collected to address, and beyond.

Today, Women in Global Health has more than 25,000 supporters in more than 90 countries and continues to grow. Dr. Roopa Dhatt, the Executive Director, and the global team work with a network of WGH chapters in every region to challenge power and privilege for gender equity in health by mobilizing a diverse group of emerging women health leaders, by advocating to existing global health leaders to commit to transform their own institutions, and by holding these leaders to account.  With more than chapters in all regions, Women in Global Health is changing the conversation about women’s leadership in health at global, national and local levels.

Taghreed is a professional expert in the pharmaceutical industry in the MENA region. In 2011, she founded Professional Effective Solutions, a company that offers consultation to pharmaceutical companies in formulating effective business plans; new products launch strategies to meet future market trends as well as turnaround management.

During the period from 1/2016 till 12/ 2016 she also held the position of Strategic Healthcare Advisor at the First Energy Bank in Abu Dhabi.

Taghreed had an instrumental role in the dramatic growth and success of Hikma in the MENA region. She was also an important member of the Hikma IPO team that helped take Hikma through the process of its transformation to an internationally recognized public company listed on the London Stock Exchange in Nov 2005.

Taghreed holds a BS.C degree in Pharmaceutical Sciences and two Master degrees from INSEAD Business School; “Executive MBA” in 2007 and “Consulting and Coaching for Change” in 2012.

Today, besides her consultancy services, Taghreed sits on the Board of other pharmaceutical companies in Jordan, Switzerland, Tunisia and the UAE, where she provides guidance and support.

The presentation is available here.

The presentation is available here.

Emer Cooke is currently Director, Regulation and Prequalification with the World Health Organization (WHO) in Geneva and has been with WHO since November 2016. In this role, Ms Cooke is responsible for leading WHO's global work on regulation of health technologies (medicines, vaccines, diagnostics, vector control products and devices), coordinating the regulatory teams (Prequalification, Regulatory Systems Strengthening, and Safety), and working with member states and international partners to assure the quality, safety and efficacy of appropriate health technologies. Ms. Cooke is a pharmacist with Masters degrees in Science and Business Administration from Trinity College Dublin. She has over 30 years’ experience in international regulatory affairs and spent 14 years (2002 to 2016) in management positions at the European Medicines Agency as head of Inspections and head of International affairs respectively.

The presentation is available here.

The presentation is available here.

The presentation is available here.

The presentation is available here.

The presentation is available here.

The presentation is available here.

Presentation is available here.

Presentation is available here.

Leonora is the founder & CEO of Pharmapod, a company that develops pioneering software to promote medication safety for patients worldwide. Leonora has 25 years’ experience in pharmacy practice, policy development and regulatory affairs. Past roles include working for the Pharmacy Regulator in Ireland and across 7 European countries for an international pharmacy group, implementing pan-European professional standards & anti-counterfeit programmes. She also held the position of Chief Pharmacist for the largest pharmacy chain in Ireland. This year Leonora won Business Woman of the Year in Ireland and is also a finalist in the EY Entrepreneur of the Year awards.

The presentation is available here.

•Doctor in Pharmacy, Complutense University of Madrid, Spain

•Community pharmacist

•General Secretary of Spanish Consejo General of Pharmacists (1997-2009)

•President of Spanish Consejo General of Pharmacists (2009-2015)

•Vice president of FIP (2006-2014)

•President of FIP (2014-2018)

•Grand Cross of the Civil Order of Health of Spain, 2015

•APSTJ Woman Scientist, The Academy of Pharmaceutical Scientist of Japan, 2015

•Encomienda / Medal of Pharmaceutical Merit of the Brazilian Federal Council of Pharmacists, 2010

•Academic of the Royal Academy of Pharmacy of Spain, Academic of the Ibero-American Academy of Pharmacy and Honorary Academic of the Medical-Surgical Academy of Spain

•Other recognitions and honors of Spain and other countries of the world.

The presentation is available here.

The presentation is available here.

The presentation is available here.

The presentation is available here.

Andy Gray is a senior lecturer in the Division of Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, former vice president, bureau member, chair BPP, Hospital Pharmacy Section President, FIP; co-director of the WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice; Honorary Senior Scientist: Consultant Pharmacist for the Centre for the AIDS Programme of Research in South Africa; Visiting Fellow, Faculty of Pharmacy, Rhodes University, Grahamstown; Member of the World Health Organization’s Expert Panel on Drug Policies and Management; Associate Editor of the South African Pharmaceutical Journal; section editor of the Journal of Pharmaceutical Policy and Practice; and serves on the editorial board of the International Journal of Clinical Pharmacy, Health Systems and Reform, and BMC Health Services Research.

Presentation is available here.

Presentation is available here

Presentation is available here

*Moderator: John Hertig

*Speakers: Mário Borges Rosa and Michael R. Cohen

On November 2016, the International Pharmaceutical Federation (FIP) brought together pharmacy leaders from across the world to set the future milestones for pharmacy education in a context of workforce development.  “There is no health without pharmacy workforce”, this slogan highlighted the importance of investing in the workforce. In addition to this, engaging youth in workforce development is unavoidable because youth are the future generation! 

FIP YPG is hosting a webinar in collaboration with the FIP Education and the International Pharmaceutical Students' Association (IPSF) on how students and young pharmacy workforce can be involved in the workforce development. If you are interested to know more about how you can engage in workforce development, this webinar is for you!

By the end of this webinar, attendees will be able to: (1) Explore current projects related to Pharmaceutical Workforce Development Goals (PWDGs); (2) Describe current project on Nanjing Assessment tools; (3) Provide examples of young student’s involvement in the Nanjing Outcomes; (4) Reflect on how pharmacy student, next generation of young pharmacists and pharmaceutical scientists can be involved.

FIP’s Hospital Pharmacy Section is organising a webinar on “Good storage and distribution practices for pharmaceutical products in hospitals”.

The correct storage and distribution and the continuous improvement of the processes involved in the supply chain from the acquisition to the administration or use of pharmaceutical products in hospitals, have a direct economic impact and improves quality assurance in patients care.

Learning objectives:

1. Understand variables that affect the stability of pharmaceutical products.

2. Understand storage and distribution processes.

3. Evaluate good storage and distribution practices that improves quality processes.

4. Highlight new technologies that benefit good practices for pharmaceutical products.

Presentation outline:

- Define variables that affect the stability of pharmaceutical products.

- Define storage and distribution processes for pharmaceutical products.

- Provide examples of good practices.

- Present new technologies that benefit good practices of storage and distribution.

Moderator: Nora Gerpe

Speakers: Martín G. Silveira and Javier Movilla

fip, webinar, hps

2016-11-03 AIM Webinar_ Leadership Development – for you and your faculty team!

2016-10-26 08.01 AcPS Webinar Leadership Development – for you and your students!

HPS - Substandard, Spurious, Falsely Labelled, Falsified, and Counterfeit (SSFFC) Medication Issues and Managem